Amend CSSB 694 by Bettencourt, by adding the following to Section 1 (5) on lines 1-43 to 1-47: the use of available investigational drugs, biological products, and devices is a decision that should be made by the patient with a terminal illness in consultation with the patient's physician to pursue the preservation of their own life and is not a decision to be made by the government; and